biosimilar
Most Read
Do biologics really need 12 years of market exclusivity?
FDA finalizes rules for when a biosimilar is ‘interchangeable’ with a biologic
Are concerns about a price war between Johnson & Johnson and Pfizer ‘overblown’?
The world’s best-selling drug is in line for cheaper competition — eventually
Pharmalot, Pharmalittle: FDA approves a biosimilar version of Enbrel
Biosimilar names may affect pharmacist dispensing habits
